{
    "info": {
        "nct_id": "NCT03747575",
        "official_title": "A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Moderate to Severe Atopic Dermatitis",
        "inclusion_criteria": "Inclusion criteria\n\n* Ability to comply with the study protocol\n* Chronic AD that has been present for at least 3 years before the screening visit\n* Documented recent history (within 6 months before the screening visit) of inadequate response to treatment with topical medications (medications or treatments applied directly to part of the body) or for whom topical treatments are otherwise medically inadvisable\n\nExclusion criteria\n\n* Prior treatment with MSTT1041A\n* Treatment with any investigational therapy (with the exception of biologics) within 8 weeks or within 5 half-lives whichever is longer, before screening\n* Treatment with any cell-depleting agents within 6 months before screening, or until lymphocyte count returns to normal, whichever is longer\n* Treatment with other biologics within 3 months or 5 half-lives before screening, whichever is longer\n* Comorbid conditions that may interfere with evaluation of investigational medicinal product\n* History or evidence of substance abuse that would pose a risk to participant safety, interfere with the conduct of the study, have an impact on the study results, or affect the participant's ability to participate in the study\n* History of anaphylaxis, hypersensitivity to a biologic agent, or known hypersensitivity to any component of the MSTT1041A or placebo injection\n* Planned surgical intervention during the course of the study\n* Pregnant or breastfeeding, or intending to become pregnant during the study\n* Participant who is a member of the investigational team or his/her immediate family\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
        "exclusion_criteria": "",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Prior treatment with MSTT1041A",
            "criterions": [
                {
                    "exact_snippets": "Prior treatment with MSTT1041A",
                    "criterion": "treatment with MSTT1041A",
                    "requirements": [
                        {
                            "requirement_type": "prior exposure",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Exclusion criteria",
            "criterions": [
                {
                    "exact_snippets": "Exclusion criteria",
                    "criterion": "exclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability to comply with the study protocol",
            "criterions": [
                {
                    "exact_snippets": "Ability to comply with the study protocol",
                    "criterion": "ability to comply with study protocol",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Treatment with any investigational therapy (with the exception of biologics) within 8 weeks or within 5 half-lives whichever is longer, before screening",
            "criterions": [
                {
                    "exact_snippets": "Treatment with any investigational therapy (with the exception of biologics) within 8 weeks or within 5 half-lives whichever is longer, before screening",
                    "criterion": "treatment with investigational therapy (excluding biologics)",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": -8,
                                        "unit": "weeks"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": -5,
                                        "unit": "half-lives"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History or evidence of substance abuse that would pose a risk to participant safety, interfere with the conduct of the study, have an impact on the study results, or affect the participant's ability to participate in the study",
            "criterions": [
                {
                    "exact_snippets": "History or evidence of substance abuse that would pose a risk to participant safety, interfere with the conduct of the study, have an impact on the study results, or affect the participant's ability to participate in the study",
                    "criterion": "substance abuse",
                    "requirements": [
                        {
                            "requirement_type": "history or evidence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "risk to participant safety",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "interference with conduct of the study",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "impact on study results",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "affect participant's ability to participate",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Chronic AD that has been present for at least 3 years before the screening visit",
            "criterions": [
                {
                    "exact_snippets": "Chronic AD that has been present for at least 3 years before the screening visit",
                    "criterion": "atopic dermatitis (AD)",
                    "requirements": [
                        {
                            "requirement_type": "chronicity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Documented recent history (within 6 months before the screening visit) of inadequate response to treatment with topical medications (medications or treatments applied directly to part of the body) or for whom topical treatments are otherwise medically inadvisable",
            "criterions": [
                {
                    "exact_snippets": "Documented recent history (within 6 months before the screening visit) of inadequate response to treatment with topical medications",
                    "criterion": "response to topical medications",
                    "requirements": [
                        {
                            "requirement_type": "response adequacy",
                            "expected_value": "inadequate"
                        },
                        {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "for whom topical treatments are otherwise medically inadvisable",
                    "criterion": "medical advisability of topical treatments",
                    "requirements": [
                        {
                            "requirement_type": "medical advisability",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Treatment with any cell-depleting agents within 6 months before screening, or until lymphocyte count returns to normal, whichever is longer",
            "criterions": [
                {
                    "exact_snippets": "Treatment with any cell-depleting agents within 6 months before screening",
                    "criterion": "treatment with cell-depleting agents",
                    "requirements": [
                        {
                            "requirement_type": "time since last treatment",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "until lymphocyte count returns to normal",
                    "criterion": "lymphocyte count",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "normal"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Comorbid conditions that may interfere with evaluation of investigational medicinal product",
            "criterions": [
                {
                    "exact_snippets": "Comorbid conditions that may interfere with evaluation of investigational medicinal product",
                    "criterion": "comorbid conditions",
                    "requirements": [
                        {
                            "requirement_type": "potential to interfere with evaluation of investigational medicinal product",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Treatment with other biologics within 3 months or 5 half-lives before screening, whichever is longer",
            "criterions": [
                {
                    "exact_snippets": "Treatment with other biologics within 3 months or 5 half-lives before screening, whichever is longer",
                    "criterion": "treatment with other biologics",
                    "requirements": [
                        {
                            "requirement_type": "time since last treatment",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 3,
                                        "unit": "months"
                                    },
                                    {
                                        "operator": ">=",
                                        "value": 5,
                                        "unit": "half-lives"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 75 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 75 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 75,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of anaphylaxis, hypersensitivity to a biologic agent, or known hypersensitivity to any component of the MSTT1041A or placebo injection",
            "criterions": [
                {
                    "exact_snippets": "History of anaphylaxis",
                    "criterion": "anaphylaxis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hypersensitivity to a biologic agent",
                    "criterion": "hypersensitivity to a biologic agent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known hypersensitivity to any component of the MSTT1041A or placebo injection",
                    "criterion": "hypersensitivity to any component of the MSTT1041A or placebo injection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant who is a member of the investigational team or his/her immediate family",
            "criterions": [
                {
                    "exact_snippets": "Participant who is a member of the investigational team",
                    "criterion": "membership in investigational team",
                    "requirements": [
                        {
                            "requirement_type": "membership",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "his/her immediate family",
                    "criterion": "immediate family relationship to investigational team member",
                    "requirements": [
                        {
                            "requirement_type": "relationship",
                            "expected_value": "immediate family"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Planned surgical intervention during the course of the study",
            "criterions": [
                {
                    "exact_snippets": "Planned surgical intervention during the course of the study",
                    "criterion": "planned surgical intervention",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "during the course of the study"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnant or breastfeeding, or intending to become pregnant during the study",
            "criterions": [
                {
                    "exact_snippets": "Pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "intending to become pregnant during the study",
                    "criterion": "intention to become pregnant during the study",
                    "requirements": [
                        {
                            "requirement_type": "intention",
                            "expected_value": false
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "Inclusion criteria",
            "criterions": []
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}